Johnson & Johnson

Cannabis Industry's Capital Crunch: Why It Needs More Funds Than Other Industries, Will Fed Legalization Change This?
J&J, Abbott Labs And JPM Among Jim Cramer's Top Picks As Market Shifts Focus From Tech
J&J Investors Will Soon Be Able To Exchange Shares For Kenvue Stocks
J&J, Abbott Labs And JPM Among Jim Cramer's Top Picks As Market Shifts Focus From Tech
J&J Investors Will Soon Be Able To Exchange Shares For Kenvue Stocks
A Rotation Into Defensive Stocks? Market Strength Seen In Consumer Defensive And Healthcare On Tuesday
EXCLUSIVE: How Avicanna Is Advancing Plant-Derived, Cannabinoid-Based Products

Johnson & Johnson Recent News

Barron's Most Recent Picks And Pans: Airbnb, Duke Energy, Evoqua, Netflix And More
The cover story in this weekend's Barron's suggests how to play travel stocks as the recovery falters. Other featured articles discuss banking stocks with steady dividends, stocks that will benefit from share buybacks and why the boom in energy stocks may be over.
Earnings Strength From J&J, Chipotle, Coca-Cola Helps Set Positive Early Tone
The earnings parade continues, with a steady flow of solid corporate results helping Wall Street recover from Monday’s huge plunge. In fact, the major indices are basically back where they were Friday after two crazy days, making it look like Monday and Tuesday never happened. 
Sponsored
The Latest Picks And Pans From Barron's: Dividend Kings, Roundtable Picks, SAP And More
The cover story in this weekend's Barron's offers 42 bargain stock picks from the Barron's Roundtable. Other featured articles discuss disappearing Chinese stocks, the next big thing in biotech and themes to watch for in big tech earnings.
Johnson & Johnson Reaches $230M Settlement With New York State To End Sale Of Opioids Nationwide
On Saturday, Johnson & Johnson (NYSE: JNJ) said it would end the manufacture and sale of opioids nationwide in a $230 million settlement with the New York state, 
Johnson & Johnson's Vaccine Is On Hold But lts Businesses Emerged Healthier From The Pandemic
On Tuesday, Johnson & Johnson (NYSE: JNJ) reported $100 million in first-quarter sales of its single shot Covid-19 vaccine that's on hold in the U.S.
Strong Results From IBM And Johnson & Johnson Not Enough As Covid Worries Rise
If stocks fall on back-to-back days for the first time this month, you can probably blame an old culprit: Covid.
Barron's Latest Picks And Pans: Amazon, Coinbase, Disney, Johnson & Johnson And More
This weekend's Barron's cover story discusses why an American entertainment colossus has a bright future. Other featured articles show how proxy season is shaping up, and what the ramifications of the halt on one of the COVID-19 vaccines could be.
J&J Covid Vaccine Pause Appears To Weigh On Airline, Casino, Hotel Stocks Early
After a dull Monday, investors awake this morning to a couple of big news items. That being said, both the consumer price index (CPI) and a pause in the use of Johnson & Johnson’s (NYSE: JNJ) Covid vaccine seem to be having a muted impact on the market. 
Benzinga's Bulls And Bears Of The Week: Apple, Chevron, GM, GE, Peloton And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. The past week's bullish calls included the iPhone maker, Google's parent and an automotive leader.
Kroger To Still Require Masks In Texas And Mississippi Stores Despite Mandate Lift
Although Texas Gov. Greg Abbott and his Mississippi counterpart Tate Reeves have announced the COVID-related mask mandates in their respective states are coming to an end, Kroger Co. (NYSE: KR) has informed shoppers in both states that they will not be able to enter their supermarkets without a mask.
Fintech Focus For March 2, 2021
Barron's Latest Picks And Pans: Berkshire Hathaway, Citigroup, Dow, Twitter And More
This weekend's Barron's cover story explores how investors can benefit from the shift to green energy. Other featured articles discuss value stocks to ride the economic recovery, what the spike in bond yields means for stocks, and tech stocks resisting the sector downturn.
The Horizons Psychedelic Stock Index ETF, As Told By Its Fund Manager
On January 27, the Horizons Psychedelic Stock Index ETF (NEO:PSYK) became the first exchange traded fund to focus solely on the psychedelics industry. 
Barron's Latest Picks And Pans: Roundtable Picks, Quantumscape, Commodities And More
This weekend's Barron's cover story explains why the online renegades that took the investing world by storm are just getting started.
Investors Eye Vaccine Results From JNJ, Novavax Amid Broader Market Uncertainty
The last day of a volatile and heavily traded stock market week opens this morning with investors apparently feeling uneasy given the state of certain speculative trades that have been in the spotlight for days.
Earnings Continue With Johnson & Johnson, 3M Early, Followed By Microsoft Later
Trying to keep up with all the earnings news? It’s a challenge, but a welcome one for many investors anxious to see how Q4 turned out for the major companies. 
BioSig Technologies Achieves First Commercial Sale Of Its PURE EP System
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Sponsored
Exclusive: Marketing Pro Craig Greiwe On How The Biggest Personalities, Media Houses Like Lionsgate Can Grow During The Pandemic
The pandemic devastated the global economy, forcing businesses and content providers to rethink their marketing and communications strategies.
Barron's Latest Picks And Pans: Airbnb, Bank Stocks, Dividend Aristocrats And More
This weekend's Barron's offers the guidance of a variety of experts on what's ahead for the global economy and the markets.
Stock Market Update For The Week Ahead: 'Positive Performance Regardless Of Which Party Wins'
The Past Week, In A Nutshell What Happened: Last week ended negative despite better-than-expected earnings.
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of October 19th – 25th, 2020. Without further ado, let’s get started.
'Further Gains Ahead': Stock Market Update For The Week Ahead
The Past Week, In A Nutshell What Happened: Last week ended negative alongside mixed messaging on stimulus.
'Continued Economic Rebound': Stock Market Update For The Week Ahead
The Past Week, In A Nutshell What Happened: Last week ended positive alongside vaccine optimism and a retail sales beat.